NCT06302218View on ClinicalTrials.gov

ESPB vs iPACK+ACB in Total Knee Arthroplasty

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 30, 2025

Conditions
Knee ArthritisKnee ArthropathyKnee OsteoarthritisKnee Pain ChronicKnee DiseaseKnee Rheumatism
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

iPACK block + Adductor Canal Block

DRUG

Ropivacaine 0.2% Injectable Solution

Erector Spinae Plane Block

DRUG

control group

only spinal anesthesia

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER